Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
OCX
Stock Latest News
Company Announcements
OncoCyte Rebrands to Insight Molecular Diagnostics
1y ago
8K
OCX
Premium
The Fly
OncoCyte changes name to Insight Molecular Diagnostics
1y ago
OCX
Premium
The Fly
Needham medtech & diagnostics analyst holds analyst/industry conference call
1y ago
OCX
BLDE
Premium
The Fly
OncoCyte reports Medicare boosts reimbursement for GraftAssureCore
1y ago
OCX
Premium
The Fly
OncoCyte price target raised to $8 from $5 at Lake Street
1y ago
OCX
Premium
Company Announcements
OncoCyte Corp’s Earnings Call: Optimism Amid Challenges
1y ago
OCX
Premium
Ratings
OncoCyte’s Strategic Initiatives and Financial Management Drive Buy Rating
1y ago
OCX
Premium
Company Announcements
OncoCyte Corp Reports Revenue Growth Amid Losses
1y ago
OCX
Premium
Pre-Earnings
OCX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1y ago
OCX
Premium
The Fly
OncoCyte provides update on progress toward initiating clinical trial
1y ago
OCX
Premium
The Fly
OncoCyte announces new publication on transplant rejection assay
1y ago
OCX
Premium
Ratings
OncoCyte Positioned for Growth: Buy Rating Affirmed by Michael Matson
2y ago
OCX
Premium
The Fly
OncoCyte files to sell 10.61M shares of common stock for holders
2y ago
OCX
Premium
Ratings
OncoCyte’s Strategic Positioning and Growth Potential in Transplant Rejection Testing
2y ago
OCX
Premium
The Fly
OncoCyte initiated with a Buy at Lake Street
2y ago
OCX
Premium
Company Announcements
OncoCyte Corp’s Positive Earnings Call Highlights Growth
2y ago
OCX
Premium
The Fly
OncoCyte reports Q4 EPS ($1.93) vs. ($1.96) last year
2y ago
OCX
Premium
Ratings
Positive Outlook on OncoCyte’s Stock Due to Strategic Launch and Financial Management
2y ago
OCX
Premium
Company Announcements
Oncocyte Corp Reports 2024 Success and 2025 Growth Plans
2y ago
OCX
Premium
Pre-Earnings
OCX Upcoming Earnings Report: What to Expect?
2y ago
OCX
Premium
Company Announcements
OncoCyte Announces Executive Promotions and Compensation Changes
2y ago
8K
OCX
Premium
Company Announcements
OncoCyte’s $29.1M Funding Through Securities Agreements
2y ago
8K
OCX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
